Kolexia
Benajiba Lina Hématologie
Benajiba Lina
Hématologie
Hôpital Saint-Louis
Paris, France
97 Activités
421 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémie aigüe myéloïde Leucémies Leucémie myéloïde COVID-19 Syndromes myéloprolifératifs Myélome multiple Myélofibrose primitive Sarcomes Hémolyse

Collaborateurs

Voir plus
Kiladjian Jean-Jacques
Kiladjian Jean-Jacques
Hôpital Saint-Louis, Paris, France
Maslah Nabih
Maslah Nabih
Hôpital Saint-Louis, Paris, France
Cassinat Bruno
Cassinat Bruno
Hôpital Saint-Louis, Paris, France
Zhao Lin-Pierre
Zhao Lin-Pierre
Hôpital Saint-Louis, Paris, France

Industries

Voir plus
KEPHREN
2 collaboration(s)
Dernière en 2023
BMS
2 collaboration(s)
Dernière en 2023
GSK
2 collaboration(s)
Dernière en 2023
Novartis
1 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM.
American journal of hematology   25 février 2024
Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC-PM.
American journal of hematology   26 janvier 2024
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification.
Leukemia   27 décembre 2023
Study of Safety, Efficacy, Tolerability, Pharmacokinetics and Pharmacodynamics of LNP023 in in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH): An Open Label, Single Arm, Multiple Dose Study to Assess Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of LNP023 When Administered in Addition to Standard of Care (SoC) in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) With Signs of Active Hemolysis
Essai Clinique (Novartis)   15 décembre 2023
Platelet Response in Pacritinib-Treated Patients with Cytopenic Myelofibrosis: A Retrospective Analysis of PERSIST-2 and PAC203 Studies
65th ASH Annual Meeting Abstracts   02 novembre 2023
The Splicing-Associated Network PAK1-Clk-SRRM1 Is a Critical Vulnerability to Overcome Chemoresistance in Acute Myeloid Leukemia
65th ASH Annual Meeting Abstracts   02 novembre 2023
Clinical features and genomic landscape of myeloproliferative neoplasm (MPN) patients with autoimmune and inflammatory diseases (AID).
Leukemia   11 juillet 2023
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Abstract CT026: A first-in-human phase 1 study of LY3410738, a covalent inhibitor of mutant IDH, in advanced myeloid malignancies
Proceedings: AACR Annual Meeting 2023   15 avril 2023
Clonal architecture evolution in Myeloproliferative Neoplasms: from a driver mutation to a complex heterogeneous mutational and phenotypic landscape.
Leukemia   31 mars 2023